Cargando…
Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
Many meta‐analyses have been published about the efficacy of hydroxychloroquine (HCQ) in coronavirus disease 2019 (COVID‐19). Most of them included observational studies, and few have assessed HCQ as a prophylaxis or evaluated its safety profile. We searched multiple databases and preprint servers f...
Autores principales: | Kashour, Zakariya, Kashour, Tarek, Gerberi, Danielle, Tleyjeh, Imad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013604/ https://www.ncbi.nlm.nih.gov/pubmed/33606894 http://dx.doi.org/10.1111/cts.13001 |
Ejemplares similares
-
It is time to drop hydroxychloroquine from our COVID-19 armamentarium
por: Kashour, Tarek, et al.
Publicado: (2020) -
Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2020) -
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
por: Tleyjeh, Imad M., et al.
Publicado: (2021) -
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
por: Kashour, Tarek, et al.
Publicado: (2021) -
Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York City
por: Tleyjeh, Imad M., et al.
Publicado: (2021)